“The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells”. Immunity37 (4): 649–59. (October 2012). doi:10.1016/j.immuni.2012.08.015. PMID23063330.
“Developing lymph nodes collect CD4+CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells”. Immunity7 (4): 493–504. (October 1997). doi:10.1016/S1074-7613(00)80371-4. PMID9354470.
“Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages”. Cell157 (2): 340–356. (April 2014). doi:10.1016/j.cell.2014.03.030. PMID24725403.
“NFIL3 orchestrates the emergence of common helper innate lymphoid cell precursors”. Cell Reports10 (12): 2043–54. (March 2015). doi:10.1016/j.celrep.2015.02.057. PMID25801035.
“The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells”. Cell126 (6): 1121–33. (September 2006). doi:10.1016/j.cell.2006.07.035. PMID16990136.
“IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways”. Nature Immunology8 (9): 967–74. (September 2007). doi:10.1038/ni1488. PMID17581537.
“Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumor immunity”. Journal of Immunology188 (2): 703–13. (January 2012). doi:10.4049/jimmunol.1101270. PMID22174445.
“Activation of Type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during Streptococcus pneumoniae infection”. The Journal of Infectious Diseases210 (3): 493–503. (August 2014). doi:10.1093/infdis/jiu106. PMID24577508.
“Perturbations of natural killer cell regulatory functions in respiratory allergic diseases”. The Journal of Allergy and Clinical Immunology121 (2): 479–85. (February 2008). doi:10.1016/j.jaci.2007.09.047. PMID18061653.
“IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs”. Nature Immunology17 (6): 636–45. (June 2016). doi:10.1038/ni.3444. PMID27111145.
“Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria”. Immunity43 (1): 146–60. (July 2015). doi:10.1016/j.immuni.2015.06.019. PMID26187413.
“Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells”. Nature Immunology18 (9): 1004–1015. (September 2017). doi:10.1038/ni.3800. PMID28759001.
“The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells”. Immunity37 (4): 649–59. (October 2012). doi:10.1016/j.immuni.2012.08.015. PMID23063330.
“Developing lymph nodes collect CD4+CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells”. Immunity7 (4): 493–504. (October 1997). doi:10.1016/S1074-7613(00)80371-4. PMID9354470.
“Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages”. Cell157 (2): 340–356. (April 2014). doi:10.1016/j.cell.2014.03.030. PMID24725403.
“NFIL3 orchestrates the emergence of common helper innate lymphoid cell precursors”. Cell Reports10 (12): 2043–54. (March 2015). doi:10.1016/j.celrep.2015.02.057. PMID25801035.
“The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells”. Cell126 (6): 1121–33. (September 2006). doi:10.1016/j.cell.2006.07.035. PMID16990136.
“IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways”. Nature Immunology8 (9): 967–74. (September 2007). doi:10.1038/ni1488. PMID17581537.
“Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumor immunity”. Journal of Immunology188 (2): 703–13. (January 2012). doi:10.4049/jimmunol.1101270. PMID22174445.
“Activation of Type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during Streptococcus pneumoniae infection”. The Journal of Infectious Diseases210 (3): 493–503. (August 2014). doi:10.1093/infdis/jiu106. PMID24577508.
“Perturbations of natural killer cell regulatory functions in respiratory allergic diseases”. The Journal of Allergy and Clinical Immunology121 (2): 479–85. (February 2008). doi:10.1016/j.jaci.2007.09.047. PMID18061653.
“IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs”. Nature Immunology17 (6): 636–45. (June 2016). doi:10.1038/ni.3444. PMID27111145.
“Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria”. Immunity43 (1): 146–60. (July 2015). doi:10.1016/j.immuni.2015.06.019. PMID26187413.
“Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells”. Nature Immunology18 (9): 1004–1015. (September 2017). doi:10.1038/ni.3800. PMID28759001.